BRIVIACT

BRIVIACT is an anti-epileptic drug used to treat partial ones seizures. Since winning the business two years ago I’ve help lead the BRIVIACT creative teams create several multi-channel HCP campaigns. Through these campaigns we’ve helped neurologists get their patients to experience long-lasting seizure control sooner. Most recently we successfully launched the pediatric indication to HCPs which was approved in September 2021.